The Biotechnology of Transgenics
Author:
Pappas Michael G.
Reference146 articles.
1. Allison, J., I.L. Campbell, G. Morahan, T.E. Mandel, L.C. Harrison, and J.F.A.P. Miller. 1988. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic 13 cells.Nature (London)333:529–533.
2. Ammirato, P.V., D.A. Evans, C.E. Flick, R.J. Whitaker, and W.R. Sharp. 1984. Biotechnology and agricultural improvements.Trends Biotechnol.2:53–58.
3. Anderson, D. and W.F.J. Cuthbertson. 1987. Safety testing of novel food products generated by biotechnology and genetic manipulation.Biotechnol. Genetic Eng. Rev.5:369–396.
4. Balcells, L., J. Swinburne, and G. Coupland. 1991. Transposons as tools for the isolation of plant genes.Tibtech.9:31–36.
5. Baribault, H. and R. Kemler. 1989. Embryonic stem cell culture and gene targeting in transgenic mice.Mol. Biol. Med.6:481–493.